Institutional shares held 129 Million
407K calls
216K puts
Total value of holdings $1.89B
$6M calls
$3.19M puts
Market Cap $887M
60,187,500 Shares Out.
Institutional ownership 213.56%
# of Institutions 240


Latest Institutional Activity in ARQT

Top Purchases

Q2 2025
Janus Henderson Group PLC Shares Held: 2.26M ($33.4M)
Q2 2025
Frazier Life Sciences Management, L.P. Shares Held: 9.87M ($146M)
Q2 2025
Pfm Health Sciences, LP Shares Held: 923K ($13.6M)
Q2 2025
Goldman Sachs Group Inc Shares Held: 1.89M ($27.9M)
Q2 2025
Bank Of America Corp Shares Held: 1.2M ($17.7M)

Top Sells

Q2 2025
Polar Capital Holdings PLC Shares Held: 5.01M ($73.8M)
Q2 2025
Invesco Ltd. Shares Held: 99.7K ($1.47M)
Q2 2025
Cormorant Asset Management, LP Shares Held: 1M ($14.7M)
Q2 2025
Jennison Associates LLC Shares Held: 11.1M ($164M)
Q2 2025
Simplify Asset Management Inc. Shares Held: 409K ($6.04M)

About ARQT

Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing ARQ-154, a topical foam formulation of roflumilast for the treatment of seborrheic dermatitis and scalp psoriasis; ARQ-252, a selective topical janus kinase type 1 inhibitor for hand eczema and vitiligo; and ARQ-255, a topical formulation of ARQ-252 designed to reach deeper into the skin in order to treat alopecia areata. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California.


Insider Transactions at ARQT

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
599K Shares
From 21 Insiders
Grant, award, or other acquisition 475K shares
Open market or private purchase 32.2K shares
Bona fide gift 1.99K shares
Exercise of conversion of derivative security 90.5K shares
Sell / Disposition
520K Shares
From 9 Insiders
Bona fide gift 1.99K shares
Open market or private sale 518K shares

Track Institutional and Insider Activities on ARQT

Follow Arcutis Biotherapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ARQT shares.

Notify only if

Insider Trading

Get notified when an Arcutis Biotherapeutics, Inc. insider buys or sells ARQT shares.

Notify only if

News

Receive news related to Arcutis Biotherapeutics, Inc.

Track Activities on ARQT